IMPAACT 1092: Phase IV Evaluation Of The Steady State Pharmacokinetics Of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1-Infected Children
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 18 Jul 2017
At a glance
- Drugs Lamivudine (Primary) ; Lopinavir/ritonavir (Primary) ; Zidovudine (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 12 May 2017 Planned End Date changed from 1 Nov 2017 to 1 Dec 2017.
- 12 May 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Jun 2017.
- 29 Mar 2017 Status changed from recruiting to active, no longer recruiting.